跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AT-307
首页
药物
AT-307
AT-307
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
US 8513488 B2
申请人: EMMANUEL EYAL
优先权: 2008
US
5 件公开
Thrombin generation inhibitors
US 7074892 B2
申请人: UNIV STATE CLEVELAND
优先权: 2001
US
4 件公开
Polypeptide
CN 105296450 A
申请人: DJUPON N JUTRISHN BAJOSAJENSIZ APS
优先权: 2006
CN
US
3 件公开
Neutralising antibody against dengue for use in a method of prevention and/or treatment of zika infection
US 11111274 B2
申请人: IMP INNOVATIONS LTD
优先权: 2016
US
WO
3 件公开
Method and an arrangement for separating at least one carboxylic acid and furfural from a dilute aqueous mixture thereof
US 9073847 B2
申请人: TAMINCO FINLAND OY
优先权: 2011
US
2 件公开
ISOLATED DNA FRAGMENT OF THE HUMAN A33 PROMOTER AND ITS USE TO CONTROL THE EXPRESSION OF A HETEROLOGOUS GENE IN TUMOR CELLS
US 2010113569 A1
申请人: INIS BIOTECH LLC
优先权: 2007
US
Washing separation system on etoxazole production line
CN 210993967 U
申请人: JINGMEN JINXIADA BIOLOGICAL TECH CO LTD
优先权: 2019
CN
Application of OR protein in drought resisting process of plants
CN 117143882 A
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2022
CN
MODULATION OF IN VIVO CARDIAC PERFORMANCE USING HYPER PHOSPHOMIMETIC CMYBP-C
WO 2025184600 A1
申请人: UNIV CASE WESTERN RESERVE
优先权: 2024
WO
BISPECIFIC ANTIBODY TARGETING EGFR AND AXL, DRUG CONJUGATE THEREOF, AND USE THEREOF
WO 2025194412 A1
申请人: BEIJING BIOSTARGEN BIOTECHNOLOGY CO LTD
优先权: 2024
WO
第 1 / 2 页
上一页
下一页
药物
反馈